Long noncoding RNAs: role and contribution in pancreatic cancer. 2021

K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
Department of Biotechnology, School of Bioengineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Tamil Nadu, India.

Noncoding RNAs are proclaimed to be expressed in various cancer types and one such type is found to be pancreatic ductal adenocarcinoma (PDAC). The long noncoding RNAs (LncRNAs) affect the migration, invasion, and growth of tumor cells by playing important roles in the process of epigenesis, post-transcription, and transcriptional regulation along with the maintenance of apoptosis and cell cycle. It is quite subtle whether the alterations in lncRNAs would impact PDAC progression and development. This review throws a spotlight on the lncRNAs associated with tumor functions: MALAT-1, HOTAIR, HOXA13, H19, LINC01559, LINC00460, SNHG14, SNHG16, DLX6-AS1, MSC-AS1, ABHD11-AS1, DUXAP8, DANCR, XIST, DLEU2, etc. are upregulated lncRNAs whereas GAS5, HMlincRNA717, MIAT, LINC01111, lncRNA KCNK15-AS1, etc. are downregulated lncRNAs inhibiting the invasion and progression of PDAC. These data provided helps in the assessment of lncRNAs in the development, metastasis, and occurrence of PDAC and also play a vital role in the evolution of biomarkers and therapeutic agents for the treatment of PDAC.

UI MeSH Term Description Entries
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D062085 RNA, Long Noncoding A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin. LincRNA,RNA, Long Untranslated,LINC RNA,LincRNAs,Long Intergenic Non-Protein Coding RNA,Long Non-Coding RNA,Long Non-Protein-Coding RNA,Long Noncoding RNA,Long ncRNA,Long ncRNAs,RNA, Long Non-Translated,lncRNA,Long Intergenic Non Protein Coding RNA,Long Non Coding RNA,Long Non Protein Coding RNA,Long Non-Translated RNA,Long Untranslated RNA,Non-Coding RNA, Long,Non-Protein-Coding RNA, Long,Non-Translated RNA, Long,Noncoding RNA, Long,RNA, Long Non Translated,RNA, Long Non-Coding,RNA, Long Non-Protein-Coding,Untranslated RNA, Long,ncRNA, Long,ncRNAs, Long
D021441 Carcinoma, Pancreatic Ductal Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS. Pancreatic Ductal Carcinoma,Carcinoma, Ductal, Pancreatic,Duct-Cell Carcinoma of the Pancreas,Duct-Cell Carcinoma, Pancreas,Ductal Carcinoma of the Pancreas,Pancreatic Duct Cell Carcinoma,Carcinoma, Pancreas Duct-Cell,Carcinomas, Pancreas Duct-Cell,Carcinomas, Pancreatic Ductal,Duct Cell Carcinoma of the Pancreas,Duct Cell Carcinoma, Pancreas,Duct-Cell Carcinomas, Pancreas,Ductal Carcinoma, Pancreatic,Ductal Carcinomas, Pancreatic,Pancreas Duct-Cell Carcinoma,Pancreas Duct-Cell Carcinomas,Pancreatic Ductal Carcinomas

Related Publications

K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
August 2022, Drug discovery today,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
January 2016, World journal of gastroenterology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
February 2023, Journal of medical virology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
April 2017, Cancer letters,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
August 2022, Seminars in cancer biology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
January 2017, Theranostics,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
February 2017, Oral surgery, oral medicine, oral pathology and oral radiology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
January 2013, Nature reviews. Gastroenterology & hepatology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
January 2016, Current topics in microbiology and immunology,
K T Ramya Devi, and Dharshene Karthik, and TharunSelvam Mahendran, and M K Jaganathan, and Sanjana Prakash Hemdev
January 2018, Journal of cancer research and therapeutics,
Copied contents to your clipboard!